Quantcast
Viewing latest article 9
Browse Latest Browse All 300

Melanoma Diagnostics Leader, MELA Sciences, Hosts Clinical Advisory Meeting Friday, Dec. 6th in Conjunction with Mount Sinai Winter Dermatology Symposium (MELA Sciences Inc)

(Source: MELA Sciences Inc) New York, NY & Irvington, NY December 5, 2013 - MELA Sciences, Inc. (NASDAQ: MELA) designer and developer of MelaFind®, an FDA approved non-invasive optical device that assists dermatologists in diagnosing melanoma at its most curable stage, announces the Company will participate in the 16th Annual Mount Sinai Winter Dermatology Symposium in New York City, December 6-8, 2013. In conjunction with the Symposium, MELA will also host its second Clinical Advisory Meeting on Friday, December 6, 2013. The Mount Sinai Symposium focuses on the most current research, devices, surgical techniques, cosmetic agents and diagnosis and treatment techniques for a variety of skin...

Viewing latest article 9
Browse Latest Browse All 300

Trending Articles



<script src="https://jsc.adskeeper.com/r/s/rssing.com.1596347.js" async> </script>